UBS Lux Equity Fund Biotech USD vs DNB Aktiv 80 A
1. UBS Lux Equity Fund Biotech USD
2. DNB Aktiv 80 A
-
Security
DNB Aktiv 80 A
-
Fee
1.04%
-
ISIN
NO0010337793
-
Holdings
3
Fund Holdings
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with DNB Aktiv 80 A, we have 3 holdings where Proethos Fond is the largest holding (19.72), followed by Alfred Berg Optimal D (5.4) and Nordnet One Offensiv (2.9).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Aktiv 80 A.
UBS Lux Equity Fund Biotech USD |
DNB Aktiv 80 A |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. Proethos Fond  19.72 % |
2. Vertex Pharmaceuticals Inc 9.9 % |
2. Alfred Berg Optimal D 5.4 % |
3. Moderna Inc 9.21 % |
3. Nordnet One Offensiv NOK  2.9 % |
4. Alnylam Pharmaceuticals Inc 6.54 % |
- |
5. AbbVie Inc  5.52 % |
- |
6. Gilead Sciences Inc  4.66 % |
- |
7. Amgen Inc 4.32 % |
- |
8. BioNTech SE 4.13 % |
- |
9. Karuna Therapeutics Inc 3.75 % |
- |
10. Royalty Pharma Plc 3.28 % |
- |
The list of fund holdings was last updated on April 17, 2025.